Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03301610 · ClinicalTrials.gov registry record · NA

Mobile Educations Effect on Pain Outcomes

A NA study of Pain, Postoperative and Total Joint Arthroplasty, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
133
Enrollment target
1
Study location

NCT03301610: Completed NA study of Pain, Postoperative and Total Joint Arthroplasty, sponsored by Mayo Clinic.

NCT03301610 is a NA study of Pain, Postoperative and Total Joint Arthroplasty that has completed, run by Mayo Clinic. The registered enrollment target is 133 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03301610, a NA study of Pain, Postoperative and Total Joint Arthroplasty, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
133 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to explore the clinical impact of pain management education using a mobile web-based education delivery system compared to standard education delivery. This study seeks to understand the difference between two different education delivery methodologies and the effect on the postoperative pain experience, including participation in treatment plan, knowledge, pain outcomes, and opioid requirements in patients undergoing major hip (THA) and knee (TKA) arthroplasty. It is hypothesized that a real-time, interactive, mobile education system will demonstrate improved pain associated outcomes and higher patient participation when compared to the current standard education delivery method.

Primary Outcome

Scores are measured using a 10 point (Lickert) pain rating scale. The scale ranges from 0 to 10 with the lower score indicating less pain and the higher score indicating greater pain.

Interventions

  • OTHER Mobile Education Delivery
  • OTHER Standard Verbal and Written Education

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2017-10-23
Est. Completion 2018-02-28
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03301610 record still lists

NCT03301610 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (51% lower).

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Mobile Education Delivery is the first listed.

NCT03301610 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT03301610 about?

NCT03301610 is a clinical study titled "Mobile Educations Effect on Pain Outcomes". The purpose of this study is to explore the clinical impact of pain management education using a mobile web-based education delivery system compared to standard education delivery. This study seeks to understand the difference between two different education delivery methodologies and the effect on ...

What is the current status of trial NCT03301610?

This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2017-10-23. Estimated completion is 2018-02-28.

What conditions does trial NCT03301610 study?

This clinical trial studies the following conditions: Pain, Postoperative, Total Joint Arthroplasty.

What interventions are being tested in trial NCT03301610?

The interventions under investigation include: Mobile Education Delivery (OTHER), Standard Verbal and Written Education (OTHER).

Who is sponsoring clinical trial NCT03301610?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03301610 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03301610's enrollment target sits among peer trials

133 32nd of 113 higher than 82 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04276870 · 133 participants · Phase 2

    Orphan Indications for CD19 Redirected Autologous T Cells

  • NCT04671771 · 133 participants · NA

    A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  • NCT05610085 · 133 participants · Phase 2

    A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

  • NCT06206486 · 133 participants

    The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03301610, the US trial registry maintained by the National Library of Medicine. NCT03301610 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.